Women's preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS

Contraception

Volumn 58, Issue 4, 1998, Pages 251-255

  Hardy, Ellen ^a,b   De Pádua, Karla S ^b   Osis, Maria José D ^b   Jiménez, Ana Luisa ^b   Zaneveld, Lourens J D ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Ctro Pequisas Das Doencas M   (Brazil)

^c Prog Topical Prev Conception D   (United States)

Author keywords

AIDS; Contraception; Contraceptive usage; Market research; Sexually transmitted diseases; Vaginal formulation

Indexed keywords

CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; COLOR; COST; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERVIEW; INTRAVAGINAL DRUG ADMINISTRATION; MARKETING; NORMAL HUMAN; SEXUALLY TRANSMITTED DISEASE; SOCIAL STATUS; VAGINA CONTRACEPTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; BRAZIL; COLOR; CONSUMER SATISFACTION; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MIDDLE AGED; ODORS; PREGNANCY; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0344474508     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00106-1     Document Type: Article

References (11)

1. Hardy E., Pádua K.S., Jiménez A.L., Zaneveld L.J.D. Women's preferences for vaginal antimicrobial contraceptives I methodology . Contraception. 58:1998;233-238.
2. Hardy E., Pádua K.S., Jiménez A.L., Zaneveld L.J.D. Women's preferences for vaginal antimicrobial contraceptives II Preferred characteristics according to women's age and socioeconomic status . Contraception. 58:1998;239-244.
3. Armitage P. Statistical Methods in Medical Research. 1974;99-146 John Wiley & Sons, New York.
4. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;John Wiley & Sons, New York.
5. Chi I.-C., Smith S.C., Borko E., et al. Clinical acceptability, use-patterns and use-effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets an international multicenter randomized clinical trial . Contraception. 36:1987;499-514.
6. Hira Sk, Spruyt A.B., Feldblum P.J., et al. Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. Am J Public Health. 85:1995;1098-1103.
7. Steiner M., Spruyt A., Joanis C., et al. Acceptability of spermicidal film and foaming tablets among women in three countries. Int Fam Plann Perspect. 21:1995;104-107.
8. Stafford M.K., Ward H., Flanagan A., et al. Safety study of nonoxynol-9 as a vaginal microbicide evidence of adverse effects . J Acquir Immune Defic Syndr Hum Retrovirol. 17:1998;327-331.
9. Hardy E., Jiménez A.L., Pádua K.S., Zaneveld L.J.D. Women's preferences for vaginal antimicrobial contraceptives III preferences for formulation, applicator, and packaging . Contraception. 58:1998;245-249.
10. Ray S., Bassett M., Maposhere C., et al. Acceptability of the female condom in Zimbabwe positive but male centred responses . Reprod Health Matters. 5:1995;68-79.
11. Eldridge G.D., Lawrence J.S.S., Little C.E., et al. Barriers to condom use and barrier method preferences among low-income African-American women. Women & Health. 23:1995;73-89.